<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38672163</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Platelet-Rich Plasma (PRP) in the Treatment of Long COVID Olfactory Disorders: A Comprehensive Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">808</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12040808</ELocationID><Abstract><AbstractText><i>Background:</i> Long COVID has brought numerous challenges to healthcare, with olfactory dysfunction (OD) being a particularly distressing outcome for many patients. The persistent loss of smell significantly diminishes the affected individual's quality of life. Recent attention has been drawn to the potential of platelet-rich plasma (PRP) therapy as a treatment for OD. This comprehensive review aims to evaluate the effectiveness of PRP therapy in ameliorating OD, especially when associated with long-term COVID-19. <i>Methods:</i> We executed a comprehensive search of the literature, encompassing clinical trials and observational studies that utilized PRP in treating OD limited to COVID-19. We retrieved and comprehensively discussed data such as design, participant demographics, and reported outcomes, focusing on the efficacy and safety of PRP therapy for OD in COVID-19 patients. <i>Results:</i> Our comprehensive analysis interestingly found promising perspectives for PRP in OD following COVID-19 infection. The collective data indicate that PRP therapy contributed to a significant improvement in olfactory function after COVID-19 infection. <i>Conclusions:</i> The evidence amassed suggests that PRP is a promising and safe therapeutic option for OD, including cases attributable to Long COVID-19. The observed uniform enhancement of olfactory function in patients receiving PRP highlights the necessity for well-designed, controlled trials. Such studies would help to refine treatment protocols and more definitively ascertain the efficacy of PRP in a broader, more varied patient cohort.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maniaci</LastName><ForeName>Antonino</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1251-0185</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Enna "Kore", Piazza dell'Universit&#xe0;, 94100 Enna, EN, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Committee of Young Otolaryngologists of International Federation of Otorhinolaryngological Societies (World Ear, Nose, and Throat Federation), 13005 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavalle</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Enna "Kore", Piazza dell'Universit&#xe0;, 94100 Enna, EN, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masiello</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0007-0810-409X</Identifier><AffiliationInfo><Affiliation>Clinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 60, 20132 Milan, MI, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lechien</LastName><ForeName>Jerome R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-0845-0845</Identifier><AffiliationInfo><Affiliation>Research Committee of Young Otolaryngologists of International Federation of Otorhinolaryngological Societies (World Ear, Nose, and Throat Federation), 13005 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), 7000 Mons, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaira</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7789-145X</Identifier><AffiliationInfo><Affiliation>Research Committee of Young Otolaryngologists of International Federation of Otorhinolaryngological Societies (World Ear, Nose, and Throat Federation), 13005 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maxillofacial Surgery Operative Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, SS, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Science Department, Biomedical Science Ph.D. School, University of Sassari, 07100 Sassari, SS, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boscolo-Rizzo</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4635-7959</Identifier><AffiliationInfo><Affiliation>Department of Medical, Surgical, and Health Sciences, Section of Otolaryngology, University of Trieste, 34149 Trieste, TS, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musa</LastName><ForeName>Mutali</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7486-8361</Identifier><AffiliationInfo><Affiliation>Department of Optometry, University of Benin, Benin City 300238, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagliano</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8424-0068</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Enna "Kore", Piazza dell'Universit&#xe0;, 94100 Enna, EN, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eye Clinic Catania, University San Marco Hospital, Viale Carlo Azeglio Ciampi, 95121 Catania, CT, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeppieri</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0999-5545</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, University Hospital of Udine, p.le S. Maria della Misericordia 15, 33100 Udine, UD, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">olfactory dysfunction</Keyword><Keyword MajorTopicYN="N">platelet-rich plasma</Keyword><Keyword MajorTopicYN="N">smell loss</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38672163</ArticleId><ArticleId IdType="pmc">PMC11048638</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12040808</ArticleId><ArticleId IdType="pii">biomedicines12040808</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bushdid C., Magnasco M.O., Vosshall L.B., Keller A. Humans can discriminate more than 1 trillion olfactory stimuli. Science. 2014;343:1370&#x2013;1372. doi: 10.1126/science.1249168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1249168</ArticleId><ArticleId IdType="pmc">PMC4483192</ArticleId><ArticleId IdType="pubmed">24653035</ArticleId></ArticleIdList></Reference><Reference><Citation>Croy I., Nordin S., Hummel T. Olfactory disorders and quality of life&#x2014;An updated review. Chem. Senses. 2014;39:185&#x2013;194. doi: 10.1093/chemse/bjt072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjt072</ArticleId><ArticleId IdType="pubmed">24429163</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin S., Hed&#xe9;n Blomqvist E., Olsson P., Stj&#xe5;rne P., Ehnhage A. Effects of smell loss on daily life and adopted coping strategies in patients with nasal polyposis with asthma. Acta Oto-Laryngol. 2011;131:826&#x2013;832. doi: 10.3109/00016489.2010.539625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00016489.2010.539625</ArticleId><ArticleId IdType="pubmed">21595508</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.S., Jang S.S., Kim J., Hur K., Ference E., Wrobel B. Association Between Olfactory Dysfunction and Mortality in US Adults. JAMA Otolaryngol. Head Neck Surg. 2021;147:49. doi: 10.1001/jamaoto.2020.3502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.3502</ArticleId><ArticleId IdType="pmc">PMC7582225</ArticleId><ArticleId IdType="pubmed">33090196</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft K.L., Altundag A., Balungwe P., Boscolo-Rizzo P., Douglas R., Enecilla M.L.B., Fjaeldstad A.W., Fornazieri M.A., Frasnelli J., Gane S., et al. Position paper on olfactory dysfunction: 2023. Rhinology. 2023 doi: 10.4193/Rhin22.483.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin22.483</ArticleId><ArticleId IdType="pubmed">37454287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;fer L., Schriever V.A., Croy I. Human olfactory dysfunction: Causes and consequences. Cell Tissue Res. 2021;383:569. doi: 10.1007/s00441-020-03381-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-020-03381-9</ArticleId><ArticleId IdType="pmc">PMC7835667</ArticleId><ArticleId IdType="pubmed">33496882</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T., Liu D.T., M&#xfc;ller C.A., Stuck B.A., Welge-L&#xfc;ssen A., H&#xe4;hner A. Olfactory Dysfunction: Etiology, Diagnosis, and Treatment. Dtsch. Arztebl. Int. 2023;120:146. doi: 10.3238/arztebl.m2022.0411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0411</ArticleId><ArticleId IdType="pmc">PMC10198165</ArticleId><ArticleId IdType="pubmed">36647581</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkholaiwi F.M., Altamimi A.F., Almalki H.H., Almughaiseeb F.A., Alsubaie S.S., Alsayahi H.S., Alhijli F.W., Alobaishi R.S., Agrawal A., Alqahtani Z.A., et al. Olfactory dysfunction among patients with COVID-19. Saudi Med. J. 2023;44:1085&#x2013;1103. doi: 10.15537/smj.2023.44.11.20230264.</Citation><ArticleIdList><ArticleId IdType="doi">10.15537/smj.2023.44.11.20230264</ArticleId><ArticleId IdType="pmc">PMC10712775</ArticleId><ArticleId IdType="pubmed">37926445</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell J., Costanzo R.M., Reiter E.R. Head trauma and olfactory function. World J. Otorhinolaryngol. Head Neck Surg. 2018;4:39. doi: 10.1016/j.wjorl.2018.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wjorl.2018.02.001</ArticleId><ArticleId IdType="pmc">PMC6051255</ArticleId><ArticleId IdType="pubmed">30035260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmani G.S., Suh H.H., Pinto J.M. Effects of Ambient Air Pollution Exposure on Olfaction: A Review. Environ. Health Perspect. 2016;124:1683. doi: 10.1289/EHP136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/EHP136</ArticleId><ArticleId IdType="pmc">PMC5089874</ArticleId><ArticleId IdType="pubmed">27285588</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner S., Nies E. Olfactory dysfunction revisited: A reappraisal of work-related olfactory dysfunction caused by chemicals. J. Occup. Med. Toxicol. 2018;13:28. doi: 10.1186/s12995-018-0209-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12995-018-0209-6</ArticleId><ArticleId IdType="pmc">PMC6124006</ArticleId><ArticleId IdType="pubmed">30202422</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A., Malaspina D. Hidden consequences of olfactory dysfunction: A patient report series. BMC Ear Nose Throat Disord. 2013;13:8&#x2013;20. doi: 10.1186/1472-6815-13-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6815-13-8</ArticleId><ArticleId IdType="pmc">PMC3733708</ArticleId><ArticleId IdType="pubmed">23875929</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasnelli J., Fark T., Lehmann J., Gerber J., Hummel T. Brain structure is changed in congenital anosmia. Neuroimage. 2013;83:1074&#x2013;1080. doi: 10.1016/j.neuroimage.2013.07.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2013.07.070</ArticleId><ArticleId IdType="pubmed">23927902</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman A.A., Chin K.L., Landersdorfer C.B., Liew D., Ofori-Asenso R. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. Mayo Clin. Proc. 2020;95:1621&#x2013;1631. doi: 10.1016/j.mayocp.2020.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.030</ArticleId><ArticleId IdType="pmc">PMC7275152</ArticleId><ArticleId IdType="pubmed">32753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocke J., Hopkins C., Philpott C., Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: A systematic review and meta-analysis. Clin. Otolaryngol. 2020;45:914&#x2013;922. doi: 10.1111/coa.13620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.13620</ArticleId><ArticleId IdType="pmc">PMC7436734</ArticleId><ArticleId IdType="pubmed">32741085</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee A.S., Joshi S.V., Naik S., Sangle S., Abraham N.M. Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers. eClinicalMedicine. 2020;28 doi: 10.1016/j.eclinm.2020.100575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100575</ArticleId><ArticleId IdType="pmc">PMC7562772</ArticleId><ArticleId IdType="pubmed">33083773</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis B.N., Stow N.W., Lacroix J.S., Hugentobler M., Hummel T. Olfactory disorders: The patients&#x2019; view. Rhinology. 2009;47:454&#x2013;459. doi: 10.4193/Rhin08.174.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin08.174</ArticleId><ArticleId IdType="pubmed">19936376</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Ma Y., Bi W., Tang J. Exploring the research landscape of COVID-19-induced olfactory dysfunction: A bibliometric study. Front. Neurosci. 2023;17:1164901. doi: 10.3389/fnins.2023.1164901.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1164901</ArticleId><ArticleId IdType="pmc">PMC10079987</ArticleId><ArticleId IdType="pubmed">37034158</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Cheng L. Current and Emerging Treatment Options in Sinus and Nasal Diseases: A Promising Future in the Appropriate Therapies. J. Clin. Med. 2022;11:7398. doi: 10.3390/jcm11247398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247398</ArticleId><ArticleId IdType="pmc">PMC9788022</ArticleId><ArticleId IdType="pubmed">36556014</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieniak M., Oleszkiewicz A., Avaro V., Calegari F., Hummel T. Olfactory training&#x2014;Thirteen years of research reviewed. Neurosci. Biobehav. Rev. 2022;141:104853. doi: 10.1016/j.neubiorev.2022.104853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2022.104853</ArticleId><ArticleId IdType="pubmed">36064146</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa T., Ikeda K., Ishibashi T., Kobayashi M., Kondo K., Matsuwaki Y., Ogawa T., Shiga H., Suzuki M., Tsuzuki K., et al. Clinical practice guidelines for the management of olfactory dysfunction&#x2014;Secondary publication. Auris Nasus Larynx. 2019;46:653&#x2013;662. doi: 10.1016/j.anl.2019.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anl.2019.04.002</ArticleId><ArticleId IdType="pubmed">31076272</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabrizi A.G., Asadi M., Mohammadi M., Yekta A.A., Sohrabi M. Efficacy of Platelet-Rich Plasma as an Adjuvant Therapy to Endoscopic Sinus Surgery in Anosmia Patients with Sinonasal Polyposis: A Randomized Controlled Clinical Trial. Med. J. Islam. Repub. Iran. 2021;35:156. doi: 10.47176/MJIRI.35.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.47176/MJIRI.35.156</ArticleId><ArticleId IdType="pmc">PMC8932217</ArticleId><ArticleId IdType="pubmed">35341080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikumi A., Hara Y., Yoshioka T., Kanamori A., Yamazaki M. Effect of local administration of platelet-rich plasma (PRP) on peripheral nerve regeneration: An experimental study in the rabbit model. Microsurgery. 2018;38:300&#x2013;309. doi: 10.1002/micr.30263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/micr.30263</ArticleId><ArticleId IdType="pubmed">29094404</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundman E.A., Cole B.J., Fortier L.A. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am. J. Sports Med. 2011;39:2135&#x2013;2140. doi: 10.1177/0363546511417792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0363546511417792</ArticleId><ArticleId IdType="pubmed">21846925</ArticleId></ArticleIdList></Reference><Reference><Citation>Chellini F., Tani A., Vallone L., Nosi D., Pavan P., Bambi F., Orlandini S.Z., Sassoli C. Platelet-Rich Plasma Prevents In Vitro Transforming Growth Factor-&#x3b2;1-Induced Fibroblast to Myofibroblast Transition: Involvement of Vascular Endothelial Growth Factor (VEGF)-A/VEGF Receptor-1-Mediated Signaling. Cells. 2018;7:142. doi: 10.3390/cells7090142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7090142</ArticleId><ArticleId IdType="pmc">PMC6162453</ArticleId><ArticleId IdType="pubmed">30235859</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohebbi A., Hosseinzadeh F., Mohebbi S., Dehghani A. Determining the effect of platelet-rich plasma (PRP) on improving endoscopic sinus surgery: A randomized clinical trial study (RCT) Med. J. Islam. Repub. Iran. 2019;33:150. doi: 10.47176/mjiri.33.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.47176/mjiri.33.150</ArticleId><ArticleId IdType="pmc">PMC7137829</ArticleId><ArticleId IdType="pubmed">32280656</ArticleId></ArticleIdList></Reference><Reference><Citation>Nourizadeh N., Sharifi N.S., Bakhshaee M., Ghiasi S.S., Rasoulian B., Alamdari D.H. PRP-Fibrin Glue for Pain Reduction and Rapid Healing in Tonsillectomy. Iran. J. Otorhinolaryngol. 2022;34:289. doi: 10.22038/IJORL.2022.40429.2532.</Citation><ArticleIdList><ArticleId IdType="doi">10.22038/IJORL.2022.40429.2532</ArticleId><ArticleId IdType="pmc">PMC9709387</ArticleId><ArticleId IdType="pubmed">36474491</ArticleId></ArticleIdList></Reference><Reference><Citation>Albazee E., Diab S., Awad A.K., Aboeldahab H., Abdella W.S., Abu-Zaid A. The analgesic and anti-haemorrhagic efficacy of platelet-rich plasma in tonsillectomy: A systematic review and meta-analysis of randomised controlled trials. Clin. Otolaryngol. 2023;48:1&#x2013;9. doi: 10.1111/coa.13977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.13977</ArticleId><ArticleId IdType="pubmed">36029195</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Gerrah D.A. Use of PRP in Rhinoplasty. Otolaryngol. Open Access. 2016;6:1&#x2013;2. doi: 10.4172/2161-119X.1000280.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2161-119X.1000280</ArticleId></ArticleIdList></Reference><Reference><Citation>Yigit E., Kirgezen T., Ozdemir O., Ture M., Cagliyan A., Yigit O. The Effect of Platelet-Rich Fibrin on Postoperative Morbidity after Rhinoplasty: A Comparative Analysis with Respect to Edema, Ecchymosis and Pain. Med. Bull. Haseki/Haseki Tip Bul. 2022;60:240&#x2013;247. doi: 10.4274/haseki.galenos.2022.8084.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/haseki.galenos.2022.8084</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh A., Balouch B., Martha V.V., Sataloff R.T. Laryngeal Applications of Platelet Rich Plasma and Platelet Poor Plasma: A Systematic Review. J. Voice. 2024;38:248.e1&#x2013;248.e13. doi: 10.1016/j.jvoice.2021.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2021.07.007</ArticleId><ArticleId IdType="pubmed">34384663</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasak A.G., Yigit O., Araz Server E., Durna Dastan S., Gul M. The effectiveness of platelet-rich plasma in an anosmia-induced mice model. Laryngoscope. 2018;128:E157&#x2013;E162. doi: 10.1002/lary.27029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.27029</ArticleId><ArticleId IdType="pubmed">29243256</ArticleId></ArticleIdList></Reference><Reference><Citation>Nota J., Takahashi H., Hakuba N., Hato N., Gyo K. Treatment of neural anosmia by topical application of basic fibroblast growth factor-gelatin hydrogel in the nasal cavity: An experimental study in mice. JAMA Otolaryngol. Head Neck Surg. 2013;139:396&#x2013;400. doi: 10.1001/jamaoto.2013.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2013.92</ArticleId><ArticleId IdType="pubmed">23599076</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi M.F.H., Akhtar S., Ghaloo S.K., Wasif M., Pasha H.A., Dhanani R. Implication of stem cells and platelet rich plasma in otolaryngology, head and neck surgical procedures. J. Pak. Med. Assoc. 2023;73:S56&#x2013;S61. doi: 10.47391/JPMA.AKUS-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.47391/JPMA.AKUS-09</ArticleId><ArticleId IdType="pubmed">36788392</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder J.W., Rastatter J.C., Walner D.L. Effect of vascular endothelial growth factor on laryngeal wound healing in rabbits. Otolaryngol. Head Neck Surg. 2007;137:465&#x2013;470. doi: 10.1016/j.otohns.2007.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otohns.2007.04.027</ArticleId><ArticleId IdType="pubmed">17765777</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Shi Y., Wu L., Lv C., Hu Y., Shen Y. Comparative efficacy of platelet-rich plasma applied in myringoplasty: A systematic review and meta-analysis. PLoS ONE. 2021;16:e0245968. doi: 10.1371/journal.pone.0245968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245968</ArticleId><ArticleId IdType="pmc">PMC7833258</ArticleId><ArticleId IdType="pubmed">33493204</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P., Parida P.K., Preetam C., Mukherjee S., Nayak A., Pradhan P. Outcome of Temporalis Fascia Myringoplasty with and Without use of Platelet Rich Plasma: A Randomized Control Trial. Indian J. Otolaryngol. Head Neck Surg. 2022;74:3832&#x2013;3840. doi: 10.1007/s12070-021-02615-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-021-02615-8</ArticleId><ArticleId IdType="pmc">PMC9895725</ArticleId><ArticleId IdType="pubmed">36742679</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Tyagi B. Treatment of Sensorineural Hearing Loss in Children: Platelet Rich Plasma. Acta Sci. Otolaryngol. 2021;3:7&#x2013;11. doi: 10.31080/ASOL.2020.03.0164.</Citation><ArticleIdList><ArticleId IdType="doi">10.31080/ASOL.2020.03.0164</ArticleId></ArticleIdList></Reference><Reference><Citation>Khafagy Y.W., Abd Elfattah A.M., Moneir W., Salem E.H. Leukocyte- and platelet-rich fibrin: A new graft material in endoscopic repair of spontaneous CSF leaks. Eur. Arch. Otorhinolaryngol. 2018;275:2245&#x2013;2252. doi: 10.1007/s00405-018-5048-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-018-5048-7</ArticleId><ArticleId IdType="pubmed">29982939</ArticleId></ArticleIdList></Reference><Reference><Citation>Skar&#x17c;y&#x144;ska M.B., Ko&#x142;odziejak A., Gos E., Sanfis M.D., Skar&#x17c;y&#x144;ski P.H. Effectiveness of Various Treatments for Sudden Sensorineural Hearing Loss-A Retrospective Study. Life. 2022;12:96. doi: 10.3390/life12010096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12010096</ArticleId><ArticleId IdType="pmc">PMC8779405</ArticleId><ArticleId IdType="pubmed">35054488</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffa A., Nardelli D., Giorgi L., Di Giovanni S., Carnuccio L., Mangino C., Baptista P., Vacca M., Casale M. Platelet-Rich Plasma for Patients with Olfactory Dysfunction: Myth or Reality? A Systematic Review. J. Clin. Med. 2024;13:782. doi: 10.3390/jcm13030782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13030782</ArticleId><ArticleId IdType="pmc">PMC10856510</ArticleId><ArticleId IdType="pubmed">38337476</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuta S., Han B., Yamasoba T. Heterogeneous Damage to the Olfactory Epithelium in Patients with Post-Viral Olfactory Dysfunction. J. Clin. Med. 2023;12:5007. doi: 10.3390/jcm12155007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12155007</ArticleId><ArticleId IdType="pmc">PMC10419384</ArticleId><ArticleId IdType="pubmed">37568409</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Gao Y., Feng Y., Sun Z., Yu Z. Assessment of Factors Influencing the Olfactory Bulb Volume in Patients with Post-Viral Olfactory Dysfunction. Eur. Arch. Otorhinolaryngol. 2023;280:3737&#x2013;3743. doi: 10.1007/s00405-023-07932-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-023-07932-y</ArticleId><ArticleId IdType="pubmed">37004522</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellford S.A., Moseman E.A. Olfactory Immune Response to SARS-CoV-2. Cell Mol. Immunol. 2024;21:134&#x2013;143. doi: 10.1038/s41423-023-01119-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-023-01119-5</ArticleId><ArticleId IdType="pmc">PMC10806031</ArticleId><ArticleId IdType="pubmed">38143247</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.W., Wang X., Xu R.H. Revealing the Mystery of Persistent Smell Loss in Long COVID Patients. Int. J. Biol. Sci. 2022;18:4795&#x2013;4808. doi: 10.7150/ijbs.73485.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.73485</ArticleId><ArticleId IdType="pmc">PMC9305264</ArticleId><ArticleId IdType="pubmed">35874953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauve F., Nampoothiri S., Clarke S.A., Fernandois D., Ferreira Co&#xea;lho C.F., Dewisme J., Mills E.G., Ternier G., Cotellessa L., Iglesias-Garcia C., et al. Long-COVID Cognitive Impairments and Reproductive Hormone Deficits in Men May Stem from GnRH Neuronal Death. eBioMedicine. 2023;96:104784. doi: 10.1016/j.ebiom.2023.104784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104784</ArticleId><ArticleId IdType="pmc">PMC10507138</ArticleId><ArticleId IdType="pubmed">37713808</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleki K., Banazadeh M., Saghazadeh A., Rezaei N. The Involvement of the Central Nervous System in Patients with COVID-19. Rev. Neurosci. 2020;31:453&#x2013;456. doi: 10.1515/revneuro-2020-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0026</ArticleId><ArticleId IdType="pubmed">32463395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho C.Y., Salimian M., Hegert J., O&#x2019;Brien J., Choi S.G., Ames H., Morris M., Papadimitriou J.C., Mininni J., Niehaus P., et al. Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients with COVID-19. JAMA Neurol. 2022;79:544&#x2013;553. doi: 10.1001/jamaneurol.2022.0154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0154</ArticleId><ArticleId IdType="pmc">PMC9002725</ArticleId><ArticleId IdType="pubmed">35404378</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV-2 Related Microvascular Damage and Symptoms during and after COVID-19: Consequences of Capillary Transit-Time Changes, Tissue Hypoxia and Inflammation. Physiol. Rep. 2021;9:e14726. doi: 10.14814/phy2.14726.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin W.M., 3rd, Kuo H.H., Morrell C.N. Platelets: Versatile Modifiers of Innate and Adaptive Immune Responses to Transplants. Curr. Opin. Organ Transplant. 2011;16:41&#x2013;46. doi: 10.1097/MOT.0b013e3283425365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOT.0b013e3283425365</ArticleId><ArticleId IdType="pmc">PMC3160509</ArticleId><ArticleId IdType="pubmed">21157344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ushiro-Lumb I., Thorburn D. Risk of Transmission of Infections to Others after Donor-Derived Infection Transmissions. Transpl. Infect. Dis. 2022;24:e13791. doi: 10.1111/tid.13791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13791</ArticleId><ArticleId IdType="pubmed">35023237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince B., Y&#x131;ld&#x131;r&#x131;m M.E.C., Kilinc I., Oltulu P., Dadaci M. Investigation of the Development of Hypersensitivity and Hyperalgesia After Repeated Application of Platelet-Rich Plasma in Rats: An Experimental Study. Aesthet Surg. J. 2019;39:1139&#x2013;1145. doi: 10.1093/asj/sjz113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/asj/sjz113</ArticleId><ArticleId IdType="pubmed">31152170</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez A.G.M., Lana J.F.S.D., Rodrigues A.A., Luzo A.C.M., Belangero W.D., Santana M.H.A. Relevant aspects of centrifugation step in the preparation of platelet-rich plasma. ISRN Hematol. 2014;2014:176060. doi: 10.1155/2014/176060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/176060</ArticleId><ArticleId IdType="pmc">PMC4005024</ArticleId><ArticleId IdType="pubmed">25006472</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Saussez S. Injection of Platelet Rich Plasma in the Olfactory Cleft for COVID-19 Patients with Persistent Olfactory Dysfunction: Description of the Technique. Ear Nose Throat J. 2022 doi: 10.1177/01455613221124773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613221124773</ArticleId><ArticleId IdType="pmc">PMC9554570</ArticleId><ArticleId IdType="pubmed">36219733</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Jang S.S., Lin H.C., Ma Y., Khanwalkar A.R., Thai A., Patel Z.M. Use of platelet-rich plasma for COVID-19-related olfactory loss: A randomized controlled trial. Int. Forum Allergy Rhinol. 2023;13:989&#x2013;997. doi: 10.1002/alr.23116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.23116</ArticleId><ArticleId IdType="pmc">PMC9877663</ArticleId><ArticleId IdType="pubmed">36507615</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffens Y., Le Bon S.-D., Lechien J., Prunier L., Rodriguez A., Saussez S., Horoi M. Effectiveness and safety of PRP on persistent olfactory dysfunction related to COVID-19. Eur. Arch. Otorhinolaryngol. 2022;279:5951&#x2013;5953. doi: 10.1007/s00405-022-07560-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-022-07560-y</ArticleId><ArticleId IdType="pmc">PMC9336533</ArticleId><ArticleId IdType="pubmed">35904632</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo El Naga H.A., El Zaiat R.S., Hamdan A.M. The potential therapeutic effect of platelet-rich plasma in the treatment of post-COVID-19 parosmia. Egypt. J. Otolaryngol. 2022;38:130. doi: 10.1186/s43163-022-00320-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43163-022-00320-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Le Bon S.D., Saussez S. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction. Eur. Arch. Otorhinolaryngol. 2023;280:2351&#x2013;2358. doi: 10.1007/s00405-022-07788-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-022-07788-8</ArticleId><ArticleId IdType="pmc">PMC9751511</ArticleId><ArticleId IdType="pubmed">36520209</ArticleId></ArticleIdList></Reference><Reference><Citation>Evman M.D., Cetin Z.E. Effectiveness of platelet-rich plasma on post-COVID chronic olfactory dysfunction. Rev. Assoc. M&#xe9;dica Bras. 2023;69:e20230666. doi: 10.1590/1806-9282.20230666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.20230666</ArticleId><ArticleId IdType="pmc">PMC10610757</ArticleId><ArticleId IdType="pubmed">37909619</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Saussez S., Vaira L.A., De Riu G., Boscolo-Rizzo P., Tirelli G., Michel J., Radulesco T. Effectiveness of Platelet-Rich Plasma for COVID-19-Related Olfactory Dysfunction: A Controlled Study. Otolaryngol. Head Neck Surg. 2024;170:84&#x2013;91. doi: 10.1002/ohn.460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ohn.460</ArticleId><ArticleId IdType="pubmed">37522295</ArticleId></ArticleIdList></Reference><Reference><Citation>Riccardi G., Niccolini G.F., Bellizzi M.G., Fiore M., Minni A., Barbato C. Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out. Diseases. 2023;11:79. doi: 10.3390/diseases11020079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases11020079</ArticleId><ArticleId IdType="pmc">PMC10297121</ArticleId><ArticleId IdType="pubmed">37366867</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrajhi B., Alrodiman O.A., Alhuzali A.F., Alrashed H., Alrodiman Y.A., Alim B. Platelet-rich plasma for the treatment of COVID-19 related olfactory dysfunction: A systematic review. Rhinology. 2023;61:498&#x2013;507. doi: 10.4193/Rhin23.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin23.168</ArticleId><ArticleId IdType="pubmed">37772881</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohla K., Veldhuizen M., Green T., Hannum M., Bakke A., Moein S., Tognetti A., Postma E., Pellegrino R., Hwang D., et al. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss. Rhinology. 2022;60:207&#x2013;217. doi: 10.4193/Rhin21.415.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.415</ArticleId><ArticleId IdType="pmc">PMC11016179</ArticleId><ArticleId IdType="pubmed">35398877</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Aaraj M., Boorinie M., Salfity L., Eweiss A. The use of Platelet rich Plasma in COVID-19 Induced Olfactory Dysfunction: Systematic Review. Indian J. Otolaryngol. Head Neck Surg. 2023;75:3093&#x2013;3097. doi: 10.1007/s12070-023-03938-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-023-03938-4</ArticleId><ArticleId IdType="pmc">PMC10257368</ArticleId><ArticleId IdType="pubmed">37362129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Mundy D.C., Patel Z.M. The use of platelet-rich plasma in treatment of olfactory dysfunction: A pilot study. Laryngoscope Investig. Otolaryngol. 2020;5:187&#x2013;193. doi: 10.1002/lio2.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lio2.357</ArticleId><ArticleId IdType="pmc">PMC7178450</ArticleId><ArticleId IdType="pubmed">32337347</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z.-B., Chen H.-C., Wei B., Zhang Z.-M., Wu S.-K., Sun J.-C., Xiang M. Platelet rich plasma enhanced neuro-regeneration of human dental pulp stem cells in vitro and in rat spinal cord. Ann. Transl. Med. 2022;10:584. doi: 10.21037/atm-22-1745.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-22-1745</ArticleId><ArticleId IdType="pmc">PMC9201165</ArticleId><ArticleId IdType="pubmed">35722381</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrie L.E., Crowell J.A.E., Telling G.C., Bessen R.A. The cellular prion protein promotes olfactory sensory neuron survival and axon targeting during adult neurogenesis. Dev. Biol. 2018;438:23&#x2013;32. doi: 10.1016/j.ydbio.2018.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2018.03.012</ArticleId><ArticleId IdType="pmc">PMC5916339</ArticleId><ArticleId IdType="pubmed">29577883</ArticleId></ArticleIdList></Reference><Reference><Citation>Tey R.V., Haldankar P., Joshi V.R., Raj R., Maradi R. Variability in Platelet-Rich Plasma Preparations Used in Regenerative Medicine: A Comparative Analysis. Stem Cells Int. 2022;2022:3852898. doi: 10.1155/2022/3852898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3852898</ArticleId><ArticleId IdType="pmc">PMC9613381</ArticleId><ArticleId IdType="pubmed">36311042</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster K.E., O&#x2019;Byrne L., MacKeith S., Philpott C., Hopkins C., Burton M.J. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst. Rev. 2022;2022:CD013877. doi: 10.1002/14651858.CD013877.PUB3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013877.PUB3</ArticleId><ArticleId IdType="pmc">PMC9443936</ArticleId><ArticleId IdType="pubmed">36063364</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrogeni P., Kanakopoulos A., Maihoub S., Maihoub S., Krasznai M., Szirmai A. Anosmia treatment by platelet rich plasma injection. Int. Tinnitus J. 2017;20:102&#x2013;105. doi: 10.5935/0946-5448.20160019.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/0946-5448.20160019</ArticleId><ArticleId IdType="pubmed">28452719</ArticleId></ArticleIdList></Reference><Reference><Citation>Shawky M.A., Hadeya A.M. Platelet-rich Plasma in Management of Anosmia (Single Versus Double Injections) Indian J. Otolaryngol. Head Neck Surg. 2023;75:1004&#x2013;1008. doi: 10.1007/s12070-023-03553-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-023-03553-3</ArticleId><ArticleId IdType="pmc">PMC10188686</ArticleId><ArticleId IdType="pubmed">37206725</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Byrne L., Webster K.E., MacKeith S., Philpott C., Hopkins C., Burton M.J. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst. Rev. 2022;2022:CD013876. doi: 10.1002/14651858.CD013876.PUB3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013876.PUB3</ArticleId><ArticleId IdType="pmc">PMC9443431</ArticleId><ArticleId IdType="pubmed">36062970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>